Jul 24, 2024 • 30 minutes
Spotting opportunities and hurdles in a burgeoning industry.
SHARE
0
Featuring Will Tamplin and Ash Bennington
Will Tamplin, senior analyst at Fairlead Strategies, joins Ash Bennington to discuss his strategy for leveraging opportunities in the biotech sector amid market volatility — and how $XBI can have an outsized impact on your portfolio.
This content is reserved for the thousands of visionaries supporting the financial revolution. We'd love for you to join us. Interested?
Already have an account? Log In
Facebook
Twitter
LinkedIn
Reddit
COMMENTS
Sort ByAccess Plus Content
This content is reserved for the thousands of visionaries supporting the financial revolution. We'd love for you to join us. Interested?
See Our PlansAlready have an account? Log In